These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36825769)

  • 1. Triple targeting host-guest drug delivery system based on lactose-modified azocalix[4]arene for tumor ablation.
    Li JJ; Rong RX; Yang Y; Hu ZY; Hu B; Zhao YY; Li HB; Hu XY; Wang KR; Guo DS
    Mater Horiz; 2023 May; 10(5):1689-1696. PubMed ID: 36825769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active targeting tumor therapy using host-guest drug delivery system based on biotin functionalized azocalix[4]arene.
    Chen MM; Tang X; Li JJ; Chen FY; Jiang ZT; Fu R; Li HB; Hu XY; Geng WC; Guo DS
    J Control Release; 2024 Apr; 368():691-702. PubMed ID: 38492860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
    Li JJ; Hu Y; Hu B; Wang W; Xu H; Hu XY; Ding F; Li HB; Wang KR; Zhang X; Guo DS
    Nat Commun; 2022 Oct; 13(1):6279. PubMed ID: 36270992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supramolecular nanomaterials based on hollow mesoporous drug carriers and macrocycle-capped CuS nanogates for synergistic chemo-photothermal therapy.
    Yang J; Dai D; Lou X; Ma L; Wang B; Yang YW
    Theranostics; 2020; 10(2):615-629. PubMed ID: 31903141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Antitumor Dual-Responsive Host-Guest Supramolecular Polymer Based on Hypoxia-Cleavable Azocalix[4]arene.
    Yao SY; Yue YX; Ying AK; Hu XY; Li HB; Cai K; Guo DS
    Angew Chem Int Ed Engl; 2023 Jan; 62(2):e202213578. PubMed ID: 36353747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-shell tecto dendrimers formed via host-guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery.
    Wang J; Li D; Fan Y; Shi M; Yang Y; Wang L; Peng Y; Shen M; Shi X
    Nanoscale; 2019 Nov; 11(46):22343-22350. PubMed ID: 31728477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milk derived colloid as a novel drug delivery carrier for breast cancer.
    Hayashi M; Silanikove N; Chang X; Ravi R; Pham V; Baia G; Paz K; Brait M; Koch WM; Sidransky D
    Cancer Biol Ther; 2015; 16(8):1184-93. PubMed ID: 26046946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
    Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
    ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of cascade delivery and tumor hypoxia modulating capacities in core-releasable satellite nanovehicles to enhance tumor chemotherapy.
    Wang J; Wang X; Lu SY; Hu J; Zhang W; Xu L; Gu D; Yang W; Tang W; Liu F; Cao Y; Liu H
    Biomaterials; 2019 Dec; 223():119465. PubMed ID: 31518842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
    Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
    Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Supramolecular Vesicles to Micelles: Controllable Construction of Tumor-Targeting Nanocarriers Based on Host-Guest Interaction between a Pillar[5]arene-Based Prodrug and a RGD-Sulfonate Guest.
    Hu XY; Gao L; Mosel S; Ehlers M; Zellermann E; Jiang H; Knauer SK; Wang L; Schmuck C
    Small; 2018 Dec; 14(52):e1803952. PubMed ID: 30456872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release.
    Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.